Top Headlines
Pharmaceutical Business Review
GSK, US HHS team up to develop drugs against antibiotic resistance and bioterrorism
GlaxoSmithKline (GSK) has teamed up with Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and Human Services (HHS), to develop drugs against antibiotic resistance and bioterrorism.
Contract Research & Services > Contract Research > News
Duchesnay introduces Diclegis in US market
By
Duchesnay USA has announced the availability of Diclegis, a composition of 10mg doxylamine succinate and 10mg pyridoxine hydrochloride (vitamin B6), in US pharmacies.
Drug Research > Drug Discovery & Development > News Campus Biotech buys Merck Geneva headquarters By
The Campus Biotech Consortium has purchased Merck KGaA (MRK)'s Geneva headquarters to create a biotechnology campus.
Inward Investment > News Soligenix' ThermoVax technology receives US patent By
Clinical stage biopharmaceutical company Soligenix has received US patent for the vaccine thermostabilization technology, ThermoVax.
Regulatory Affairs > News
Duchesnay USA has announced the availability of Diclegis, a composition of 10mg doxylamine succinate and 10mg pyridoxine hydrochloride (vitamin B6), in US pharmacies.
Drug Research > Drug Discovery & Development > News Campus Biotech buys Merck Geneva headquarters By
The Campus Biotech Consortium has purchased Merck KGaA (MRK)'s Geneva headquarters to create a biotechnology campus.
Inward Investment > News Soligenix' ThermoVax technology receives US patent By
Clinical stage biopharmaceutical company Soligenix has received US patent for the vaccine thermostabilization technology, ThermoVax.
Regulatory Affairs > News
FDA approves entry of R-Tech ophthalmic solution into Phase I/II trials
By
The FDA has approved R-Tech Ueno's novel ophthalmic solution, developed using Novozymes Biopharma's recombinant human albumin, to enter into Phase I/II trials.
Drug Research > Drug Delivery > News Corgenix partners with Eli Lilly to develop diagnostic technology By
Corgenix Medical has collaborated with Eli Lilly to develop diagnostic technology that supports the latter's oncology pipeline program.
Automation > Laboratory Instrumentation > News Biogen Idec seeks FDA approval for Plegridy in multiple sclerosis therapy By
Biogen Idec is seeking FDA approval for Plegridy (Peginterferon Beta-1a) as multiple sclerosis (MS) medication.
Drug Research > Drug Delivery > News
The FDA has approved R-Tech Ueno's novel ophthalmic solution, developed using Novozymes Biopharma's recombinant human albumin, to enter into Phase I/II trials.
Drug Research > Drug Delivery > News Corgenix partners with Eli Lilly to develop diagnostic technology By
Corgenix Medical has collaborated with Eli Lilly to develop diagnostic technology that supports the latter's oncology pipeline program.
Automation > Laboratory Instrumentation > News Biogen Idec seeks FDA approval for Plegridy in multiple sclerosis therapy By
Biogen Idec is seeking FDA approval for Plegridy (Peginterferon Beta-1a) as multiple sclerosis (MS) medication.
Drug Research > Drug Delivery > News
Latest News and Insight by Sector
Production & Manufacturing
US Organic Group develops over-the-counter organic anti-itch ointment
US Organic Group has developed an over-the-counter organic anti-itch ointment, Anti Itchbalm, for itchy skin.
Production & Manufacturing > OTC > News
Production & Manufacturing > OTC > News
Avion unveils Prenate Chewable prenatal vitamin
Avion Pharmaceuticals has unveiled a chewable, chocolate-flavored version of the Prenate prenatal vitamin family, Prenate Chewable.
Production & Manufacturing > OTC > News
Production & Manufacturing > OTC > News
Drug Research
Duchesnay introduces Diclegis in US market
Duchesnay USA has announced the availability of Diclegis, a composition of 10mg doxylamine succinate and 10mg pyridoxine hydrochloride (vitamin B6), in US pharmacies.
Drug Research > Drug Discovery & Development > News
Drug Research > Drug Discovery & Development > News
FDA approves entry of R-Tech ophthalmic solution into Phase I/II trials
The FDA has approved R-Tech Ueno's novel ophthalmic solution, developed using Novozymes Biopharma's recombinant human albumin, to enter into Phase I/II trials.
Drug Research > Drug Delivery > News
Drug Research > Drug Delivery > News
Inward Investment
Campus Biotech buys Merck Geneva headquarters
The Campus Biotech Consortium has purchased Merck KGaA (MRK)'s Geneva headquarters to create a biotechnology campus.
Inward Investment > News
Inward Investment > News
Bayer to acquire Steigerwald Arzneimittelwerk
Bayer has signed an agreement to purchase 100% of the shares of Steigerwald Arzneimittelwerk.
Inward Investment > News
Inward Investment > News
Packaging
Contract Research & Services
GSK, US HHS team up to develop drugs against antibiotic resistance and bioterrorism
GlaxoSmithKline (GSK) has teamed up with Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and Human Services (HHS), to develop drugs against antibiotic resistance and bioterrorism.
Contract Research & Services > Contract Research > News
Contract Research & Services > Contract Research > News
Jennerex completes enrollment in Phase 2b trial of liver cancer drug
Jennerex Biotherapeutics has completed enrolling 120 patients in Phase 2b trial of Pexa-Vec (JX-594, pexastimogene devacirepvec) for the treatment of liver cancer.
Contract Research & Services > Clinical Trials > News
Contract Research & Services > Clinical Trials > News
Automation
Corgenix partners with Eli Lilly to develop diagnostic technology
Corgenix Medical has collaborated with Eli Lilly to develop diagnostic technology that supports the latter's oncology pipeline program.
Automation > Laboratory Instrumentation > News
Automation > Laboratory Instrumentation > News
Elsevier, Illumina collaborate to launch Genomics Data app
Elsevier has collaborated with Illumina to launch Genomics Data app, a sequencing and array-based solutions provider for genetics research.
Automation > IT & Software > News
Automation > IT & Software > News
Regulatory Affairs
Soligenix' ThermoVax technology receives US patent
Clinical stage biopharmaceutical company Soligenix has received US patent for the vaccine thermostabilization technology, ThermoVax.
Regulatory Affairs > News
Regulatory Affairs > News
Acorda obtains additional US patent for ampyra
Acorda Therapeutics has obtained additional US patent for ampyra covering a range of dosage strengths.
Regulatory Affairs > News
Regulatory Affairs > News
Buy the latest industry research online today!
African Pharmaceutical Directory 2013
API research into pharmaceutical companies and corporations
Reports
Buy online from $200
Training Course on Medical Approach in Diagnosis and Management of ADRs
19 September 2011
Events
Training Course on Advanced GCP Study Monitoring
19 September 2011
Events
IDMP Information Day (2nd)
23 September 2011
Events